nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—ADRB2—Amine ligand-binding receptors—DRD5—bipolar disorder	0.0229	0.0236	CbGpPWpGaD
Metipranolol—ADRB1—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.0223	0.023	CbGpPWpGaD
Metipranolol—ADRB1—Monoamine GPCRs—HTR1A—bipolar disorder	0.0162	0.0168	CbGpPWpGaD
Metipranolol—ADRB2—Monoamine GPCRs—HTR1A—bipolar disorder	0.0159	0.0164	CbGpPWpGaD
Metipranolol—ADRB1—Monoamine GPCRs—HTR2C—bipolar disorder	0.0157	0.0162	CbGpPWpGaD
Metipranolol—ADRB1—Monoamine GPCRs—DRD1—bipolar disorder	0.0157	0.0162	CbGpPWpGaD
Metipranolol—ADRB2—Monoamine GPCRs—DRD1—bipolar disorder	0.0153	0.0158	CbGpPWpGaD
Metipranolol—ADRB2—Monoamine GPCRs—HTR2C—bipolar disorder	0.0153	0.0158	CbGpPWpGaD
Metipranolol—ADRB1—Monoamine GPCRs—DRD3—bipolar disorder	0.0152	0.0157	CbGpPWpGaD
Metipranolol—ADRB2—Monoamine GPCRs—DRD3—bipolar disorder	0.0148	0.0153	CbGpPWpGaD
Metipranolol—ADRB1—Monoamine GPCRs—DRD4—bipolar disorder	0.0147	0.0152	CbGpPWpGaD
Metipranolol—ADRB2—Monoamine GPCRs—DRD4—bipolar disorder	0.0144	0.0149	CbGpPWpGaD
Metipranolol—Alprenolol—HTR1A—bipolar disorder	0.0138	0.429	CrCbGaD
Metipranolol—ADRB1—Monoamine GPCRs—DRD2—bipolar disorder	0.0137	0.0142	CbGpPWpGaD
Metipranolol—ADRB1—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0136	0.0141	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.0135	0.0139	CbGpPWpGaD
Metipranolol—ADRB2—Monoamine GPCRs—DRD2—bipolar disorder	0.0134	0.0139	CbGpPWpGaD
Metipranolol—ADRB2—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0133	0.0138	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.0132	0.0136	CbGpPWpGaD
Metipranolol—ADRB1—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0132	0.0136	CbGpPWpGaD
Metipranolol—ADRB1—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0132	0.0136	CbGpPWpGaD
Metipranolol—ADRB1—Melatonin metabolism and effects—MAOA—bipolar disorder	0.0131	0.0135	CbGpPWpGaD
Metipranolol—ADRB2—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0129	0.0133	CbGpPWpGaD
Metipranolol—ADRB2—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0129	0.0133	CbGpPWpGaD
Metipranolol—ADRB1—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0128	0.0132	CbGpPWpGaD
Metipranolol—ADRB2—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0125	0.0129	CbGpPWpGaD
Metipranolol—ADRB1—Amine ligand-binding receptors—DRD4—bipolar disorder	0.0124	0.0128	CbGpPWpGaD
Metipranolol—ADRB2—Amine ligand-binding receptors—DRD4—bipolar disorder	0.0121	0.0125	CbGpPWpGaD
Metipranolol—Pindolol—HTR1A—bipolar disorder	0.0119	0.369	CrCbGaD
Metipranolol—ADRB1—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0115	0.0119	CbGpPWpGaD
Metipranolol—ADRB2—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0113	0.0117	CbGpPWpGaD
Metipranolol—ADRB1—G alpha (s) signalling events—DRD5—bipolar disorder	0.00965	0.00997	CbGpPWpGaD
Metipranolol—ADRB1—Monoamine GPCRs—HTR2A—bipolar disorder	0.00961	0.00993	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—DRD5—bipolar disorder	0.00944	0.00975	CbGpPWpGaD
Metipranolol—ADRB2—Monoamine GPCRs—HTR2A—bipolar disorder	0.0094	0.00972	CbGpPWpGaD
Metipranolol—ADRB1—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.00858	0.00887	CbGpPWpGaD
Metipranolol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS4—bipolar disorder	0.00817	0.00844	CbGpPWpGaD
Metipranolol—ADRB1—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00808	0.00835	CbGpPWpGaD
Metipranolol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS4—bipolar disorder	0.00799	0.00826	CbGpPWpGaD
Metipranolol—ADRB2—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00791	0.00817	CbGpPWpGaD
Metipranolol—ADRB1—G alpha (s) signalling events—ADM—bipolar disorder	0.00698	0.00721	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—ADM—bipolar disorder	0.00682	0.00705	CbGpPWpGaD
Metipranolol—ADRB1—G alpha (s) signalling events—TSHB—bipolar disorder	0.0068	0.00702	CbGpPWpGaD
Metipranolol—ADRB1—G alpha (s) signalling events—PDE4B—bipolar disorder	0.0068	0.00702	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—TSHB—bipolar disorder	0.00665	0.00687	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—PDE4B—bipolar disorder	0.00665	0.00687	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Other—DRD3—bipolar disorder	0.0066	0.00681	CbGpPWpGaD
Metipranolol—Propranolol—HTR1A—bipolar disorder	0.00649	0.201	CrCbGaD
Metipranolol—ADRB2—GPCRs, Other—DRD4—bipolar disorder	0.0064	0.00662	CbGpPWpGaD
Metipranolol—ADRB2—Arf6 trafficking events—INS—bipolar disorder	0.00563	0.00582	CbGpPWpGaD
Metipranolol—ADRB1—G alpha (s) signalling events—DRD1—bipolar disorder	0.00543	0.00562	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00537	0.00555	CbGpPWpGaD
Metipranolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—bipolar disorder	0.00537	0.00555	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—DRD1—bipolar disorder	0.00532	0.00549	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00525	0.00543	CbGpPWpGaD
Metipranolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—bipolar disorder	0.00525	0.00543	CbGpPWpGaD
Metipranolol—ADRB1—G alpha (s) signalling events—ADCY2—bipolar disorder	0.00481	0.00497	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—ADCY2—bipolar disorder	0.00471	0.00486	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.0046	0.00475	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.0045	0.00465	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Other—HTR2A—bipolar disorder	0.00418	0.00432	CbGpPWpGaD
Metipranolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADCY2—bipolar disorder	0.00415	0.00429	CbGpPWpGaD
Metipranolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADCY2—bipolar disorder	0.00406	0.0042	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—DRD5—bipolar disorder	0.0035	0.00362	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—DRD5—bipolar disorder	0.00343	0.00354	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00324	0.00335	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00324	0.00335	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00317	0.00328	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00317	0.00328	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00313	0.00324	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00306	0.00317	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00302	0.00312	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00302	0.00312	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00296	0.00306	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00296	0.00306	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00293	0.00303	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00287	0.00296	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00284	0.00294	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00278	0.00287	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00268	0.00277	CbGpPWpGaD
Metipranolol—ADRB1—G alpha (s) signalling events—POMC—bipolar disorder	0.00266	0.00275	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00265	0.00274	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00264	0.00273	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00262	0.00271	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—POMC—bipolar disorder	0.0026	0.00269	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00259	0.00268	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00259	0.00268	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00259	0.00268	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00258	0.00267	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00253	0.00262	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00253	0.00262	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—ADM—bipolar disorder	0.00253	0.00262	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00251	0.00259	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—ADM—bipolar disorder	0.00248	0.00256	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—TSHB—bipolar disorder	0.00247	0.00255	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—TACR1—bipolar disorder	0.00247	0.00255	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00245	0.00254	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00244	0.00252	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—TSHB—bipolar disorder	0.00241	0.00249	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—TACR1—bipolar disorder	0.00241	0.00249	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00238	0.00246	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00227	0.00235	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00222	0.00229	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DGKH—bipolar disorder	0.00216	0.00224	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DGKH—bipolar disorder	0.00212	0.00219	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR1A—bipolar disorder	0.00204	0.00211	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—TAC1—bipolar disorder	0.00201	0.00208	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR1A—bipolar disorder	0.002	0.00207	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DRD5—bipolar disorder	0.00198	0.00205	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR2C—bipolar disorder	0.00197	0.00204	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—DRD1—bipolar disorder	0.00197	0.00204	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—TAC1—bipolar disorder	0.00197	0.00203	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DGKH—bipolar disorder	0.00197	0.00203	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—RGS4—bipolar disorder	0.00194	0.00201	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DRD5—bipolar disorder	0.00194	0.002	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR2C—bipolar disorder	0.00193	0.00199	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—DRD1—bipolar disorder	0.00193	0.00199	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DGKH—bipolar disorder	0.00192	0.00199	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—DRD3—bipolar disorder	0.00191	0.00197	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—RGS4—bipolar disorder	0.0019	0.00196	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—DRD3—bipolar disorder	0.00187	0.00193	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00186	0.00192	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—DRD4—bipolar disorder	0.00186	0.00192	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00181	0.00188	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—DRD4—bipolar disorder	0.00181	0.00188	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD5—bipolar disorder	0.0018	0.00186	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—RGS4—bipolar disorder	0.00176	0.00182	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD5—bipolar disorder	0.00176	0.00182	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—DRD2—bipolar disorder	0.00173	0.00179	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—RGS4—bipolar disorder	0.00172	0.00178	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—DRD2—bipolar disorder	0.00169	0.00175	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00159	0.00164	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00155	0.00161	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—TRPC3—bipolar disorder	0.0015	0.00155	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—TRPC3—bipolar disorder	0.00147	0.00152	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—ADM—bipolar disorder	0.00143	0.00148	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—ADM—bipolar disorder	0.0014	0.00145	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00139	0.00144	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—TACR1—bipolar disorder	0.00139	0.00144	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—TSHB—bipolar disorder	0.00139	0.00144	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—TSHB—bipolar disorder	0.00136	0.00141	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PDE4B—bipolar disorder	0.00136	0.00141	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—TACR1—bipolar disorder	0.00136	0.00141	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—TRPC3—bipolar disorder	0.00136	0.00141	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—TRPC3—bipolar disorder	0.00133	0.00138	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—ADM—bipolar disorder	0.0013	0.00134	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—ADM—bipolar disorder	0.00127	0.00131	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00127	0.00131	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PDE4B—bipolar disorder	0.00127	0.00131	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—TACR1—bipolar disorder	0.00127	0.00131	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—TSHB—bipolar disorder	0.00127	0.00131	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AKR1C4—bipolar disorder	0.00126	0.0013	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00124	0.00128	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PDE4B—bipolar disorder	0.00124	0.00128	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—TSHB—bipolar disorder	0.00124	0.00128	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—TACR1—bipolar disorder	0.00124	0.00128	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AKR1C4—bipolar disorder	0.00123	0.00128	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR2A—bipolar disorder	0.00121	0.00125	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR2A—bipolar disorder	0.00118	0.00122	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DGKH—bipolar disorder	0.00116	0.0012	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00115	0.00119	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—TAC1—bipolar disorder	0.00114	0.00117	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DGKH—bipolar disorder	0.00114	0.00117	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR1A—bipolar disorder	0.00113	0.00117	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2C—bipolar disorder	0.00112	0.00115	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DRD1—bipolar disorder	0.00112	0.00115	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—TAC1—bipolar disorder	0.00111	0.00115	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DRD1—bipolar disorder	0.00109	0.00113	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2C—bipolar disorder	0.00109	0.00113	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DRD3—bipolar disorder	0.00108	0.00112	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD5—bipolar disorder	0.00106	0.0011	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DRD3—bipolar disorder	0.00106	0.00109	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR1A—bipolar disorder	0.00105	0.00108	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DRD4—bipolar disorder	0.00105	0.00108	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RGS4—bipolar disorder	0.00104	0.00108	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD5—bipolar disorder	0.00104	0.00107	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—TAC1—bipolar disorder	0.00103	0.00107	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR1A—bipolar disorder	0.00103	0.00106	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DRD4—bipolar disorder	0.00103	0.00106	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RGS4—bipolar disorder	0.00102	0.00105	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2C—bipolar disorder	0.00101	0.00105	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD1—bipolar disorder	0.00101	0.00105	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—TAC1—bipolar disorder	0.00101	0.00104	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD1—bipolar disorder	0.000991	0.00102	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2C—bipolar disorder	0.000991	0.00102	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000987	0.00102	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD3—bipolar disorder	0.000981	0.00101	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DRD2—bipolar disorder	0.000977	0.00101	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—POMC—bipolar disorder	0.000967	0.000999	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—ADCY2—bipolar disorder	0.000965	0.000997	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD3—bipolar disorder	0.000959	0.000991	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DRD2—bipolar disorder	0.000955	0.000987	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD4—bipolar disorder	0.000952	0.000984	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—POMC—bipolar disorder	0.000946	0.000977	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD4—bipolar disorder	0.000931	0.000962	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—ADCY2—bipolar disorder	0.000896	0.000926	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD2—bipolar disorder	0.000887	0.000916	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—ADCY2—bipolar disorder	0.000877	0.000906	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD2—bipolar disorder	0.000868	0.000896	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TRPC3—bipolar disorder	0.000805	0.000832	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TRPC3—bipolar disorder	0.000787	0.000814	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADM—bipolar disorder	0.000768	0.000793	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADM—bipolar disorder	0.000751	0.000776	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PDE4B—bipolar disorder	0.000748	0.000773	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TSHB—bipolar disorder	0.000748	0.000773	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TACR1—bipolar disorder	0.000748	0.000773	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PDE4B—bipolar disorder	0.000732	0.000756	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TSHB—bipolar disorder	0.000732	0.000756	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TACR1—bipolar disorder	0.000732	0.000756	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000684	0.000707	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2A—bipolar disorder	0.000669	0.000691	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2A—bipolar disorder	0.000621	0.000642	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR1A—bipolar disorder	0.000619	0.00064	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TAC1—bipolar disorder	0.00061	0.00063	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2A—bipolar disorder	0.000608	0.000628	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR1A—bipolar disorder	0.000606	0.000626	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD1—bipolar disorder	0.000598	0.000618	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2C—bipolar disorder	0.000598	0.000618	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TAC1—bipolar disorder	0.000597	0.000617	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2C—bipolar disorder	0.000585	0.000605	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD1—bipolar disorder	0.000585	0.000605	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NTRK2—bipolar disorder	0.000582	0.000601	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD3—bipolar disorder	0.000579	0.000599	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GSK3A—bipolar disorder	0.000577	0.000596	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NTRK2—bipolar disorder	0.000569	0.000588	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD3—bipolar disorder	0.000567	0.000586	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GSK3A—bipolar disorder	0.000564	0.000583	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD4—bipolar disorder	0.000562	0.000581	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD4—bipolar disorder	0.00055	0.000568	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—POMC—bipolar disorder	0.000546	0.000564	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—POMC—bipolar disorder	0.000534	0.000552	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADCY2—bipolar disorder	0.000529	0.000547	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TCF7L2—bipolar disorder	0.000528	0.000545	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD2—bipolar disorder	0.000524	0.000541	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADCY2—bipolar disorder	0.000518	0.000535	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TCF7L2—bipolar disorder	0.000516	0.000533	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD2—bipolar disorder	0.000513	0.00053	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—POMC—bipolar disorder	0.000496	0.000513	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—POMC—bipolar disorder	0.000485	0.000501	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NTRK1—bipolar disorder	0.000474	0.00049	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NTRK1—bipolar disorder	0.000464	0.000479	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—S100B—bipolar disorder	0.000461	0.000476	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—S100B—bipolar disorder	0.000451	0.000466	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NRG1—bipolar disorder	0.000407	0.000421	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NRG1—bipolar disorder	0.000398	0.000411	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2A—bipolar disorder	0.000367	0.000379	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2A—bipolar disorder	0.000359	0.000371	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GSK3B—bipolar disorder	0.000295	0.000305	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—POMC—bipolar disorder	0.000293	0.000303	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—INS—bipolar disorder	0.000291	0.000301	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GSK3B—bipolar disorder	0.000289	0.000299	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—POMC—bipolar disorder	0.000287	0.000296	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—INS—bipolar disorder	0.000285	0.000295	CbGpPWpGaD
